David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Keros Therapeutics
KROS
$214M
| $17.3M | 0.01% |
1,297,383
+34,253
| +3% | +$462K |
|
1052
PUT
Synopsys
SNPS
$75.5B
| $17.3M | 0.01% |
33,700
+12,700
| +60% | +$5.92M |
|
1053
Acuity Brands
AYI
$10.1B
| $17.2M | 0.01% |
57,796
+24,872
| +76% | +$6.44M |
|
1054
RxSight
RXST
$260M
| $17.2M | 0.01% |
1,321,330
+1,299,330
| +5,906% | +$19.5M |
|
1055
Goldman Sachs
GS
$302B
| $17.2M | 0.01% |
24,257
-31,537
| -57% | -$18.3M |
|
1056
BrightSpring Health Services Unit
BTSGU
$1.57B
| $17.1M | 0.01% |
207,300
-1,152,700
| -85% | -$85.2M |
|
1057
Imperial Oil
IMO
$66.2B
| $17.1M | 0.01% |
214,773
+30,037
| +16% | +$2.14M |
|
1058
Cable One
CABO
$130M
| $17.1M | 0.01% |
+125,634
| New | +$23.6M |
|
1059
PUT
Philip Morris
PM
$298B
| $17M | 0.01% |
93,600
-71,100
| -43% | -$12.2M |
|
1060
State Street Technology Select Sector SPDR ETF
XLK
$117B
| $17M | 0.01% |
134,174
-88,496
| -40% | -$9.82M |
|
1061
Brookfield Asset Management
BAM
$83.6B
| $17M | 0.01% |
307,093
+141,207
| +85% | +$7.58M |
|
|
B
1062
PUT
Barrick Mining
B
$79.3B
| $17M | 0.01% |
815,000
-2,277,300
| -74% | -$44.5M |
|
1063
PUT
Apollo Global Management
APO
$78.4B
| $17M | 0.01% |
119,600
-9,400
| -7% | -$1.25M |
|
1064
Granite Construction
GVA
$5.47B
| $17M | 0.01% |
181,284
+67,128
| +59% | +$5.66M |
|
1065
Sportradar
SRAD
$3.88B
| $16.9M | 0.01% |
602,398
+128,571
| +27% | +$3.05M |
|
|
JBS
1066
JBS N.V.
JBS
$45.7B
| $16.9M | 0.01% |
+1,155,860
| New | +$16.3M |
|
1067
PUT
Berkshire Hathaway Class B
BRK.B
$1.08T
| $16.9M | 0.01% |
34,700
+27,900
| +410% | +$14.2M |
|
1068
Innovative Industrial Properties
IIPR
$1.57B
| $16.8M | 0.01% |
305,132
+102,196
| +50% | +$5.59M |
|
1069
CALL
Ferrari
RACE
$74.6B
| $16.8M | 0.01% |
34,300
-1,000
| -3% | -$465K |
|
1070
PUT
McDonald's
MCD
$193B
| $16.8M | 0.01% |
57,400
+15,900
| +38% | +$4.9M |
|
1071
The Greenbrier Companies
GBX
$1.43B
| $16.8M | 0.01% |
363,875
+139,118
| +62% | +$6.23M |
|
1072
Travere Therapeutics
TVTX
$6.15B
| $16.7M | 0.01% |
1,130,750
-582,842
| -34% | -$9.66M |
|
1073
Starbucks
SBUX
$123B
| $16.7M | 0.01% |
182,633
-267,141
| -59% | -$23.2M |
|
1074
Encore Capital Group
ECPG
$2.19B
| $16.7M | 0.01% |
430,651
+117,825
| +38% | +$4.27M |
|
1075
LifeMD
LFMD
$151M
| $16.6M | 0.01% |
1,219,804
+643,978
| +112% | +$6.08M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.